Bernard Bégaud
Impact in
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes
- Toxicology top 0.1%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Pharmacology 38
- Inflammatory mediators and NSAID effects 16
- Pharmaceutical industry and healthcare 10
-
- Schizophrenia research and treatment 19
- Co-authors
- Nicholas Moore (46 shared papers)Hélène Verdoux (21 shared papers)Alexandre Pariente (28 shared papers)Éric Bruckert (1 shared paper)Gilles Hayem (1 shared paper)S. Dejager (1 shared paper)Yola Moride (18 shared papers)Marie Tournier (21 shared papers)
In The Last Decade
Bernard Bégaud
175 papers receiving 6.5k citations
Bernard Bégaud's Hit Papers
Peers
Comparison fields: 5 of 165
- Geriatrics and Gerontology 840
- Toxicology 565
- Psychiatry and Mental health 1.3k
- Pharmacology 1.1k
- Experimental and Cognitive Psychology 655
Countries citing papers authored by Bernard Bégaud
This map shows the geographic impact of Bernard Bégaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Bégaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Bégaud more than expected).
Fields of papers citing papers by Bernard Bégaud
This network shows the impact of papers produced by Bernard Bégaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Bégaud. The network helps show where Bernard Bégaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Bégaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study Hit paper breakdown → | 2005 | 926 |
| 2 | Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension Hit paper breakdown → | 1996 | 813 |
| 3 | 2006 | 468 | |
| 4 | Benzodiazepine use and risk of Alzheimer's disease: case-control study Hit paper breakdown → | 2014 | 380 |
| 5 | 2012 | 303 | |
| 6 | 1998 | 203 | |
| 7 | 2009 | 189 | |
| 8 | 1998 | 169 | |
| 9 | 2000 | 142 | |
| 10 | 2007 | 122 | |
| 11 | 2010 | 121 | |
| 12 | 2015 | 99 | |
| 13 | 2002 | 96 | |
| 14 | 2004 | 87 | |
| 15 | 2005 | 77 | |
| 16 | 2002 | 73 | |
| 17 | 2015 | 72 | |
| 18 | 2016 | 71 | |
| 19 | 2017 | 70 | |
| 20 | 2015 | 69 |
About Bernard Bégaud
Bernard Bégaud is a scholar working on Pharmacology, Psychiatry and Mental health, Geriatrics and Gerontology, Toxicology and Economics and Econometrics, having authored 179 papers that have together received 6.8k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (33 papers), Pharmacovigilance and Adverse Drug Reactions (25 papers), Schizophrenia research and treatment (19 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Inflammatory mediators and NSAID effects (16 papers), Sleep and related disorders (13 papers), Pharmaceutical studies and practices (12 papers) and Pharmaceutical industry and healthcare (10 papers). The work is most often cited by research in Geriatrics and Gerontology (840 citations), Toxicology (565 citations), Psychiatry and Mental health (1.3k citations), Pharmacology (1.1k citations) and Experimental and Cognitive Psychology (655 citations). Bernard Bégaud has collaborated with scholars based in France, Canada and Belize. Frequent co-authors include Nicholas Moore, Hélène Verdoux, Alexandre Pariente, Éric Bruckert, Gilles Hayem, S. Dejager, Yola Moride, Marie Tournier, Sophie Billioti de Gage and Rajaa Lagnaoui. Their work appears in journals such as European Journal of Clinical Pharmacology, Drug Safety, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology and Acta Psychiatrica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.